Scott Smith | Senior Vice President and Chief Financial Officer |
Jan Mikkelsen | President and Chief Executive Officer |
Mark Bach | Head, Clinical Development and Medical Affairs, Endocrinology Rare Diseases |
Jesper Høiland | Global Chief Commercial Officer |
Dana Pizzuti | Head, Development Operations |
Juha Punnonen | Head, Oncology |
Michelle Gilson | Canaccord Genuity |
Jessica Fye | JPMorgan |
Alethia Young | Cantor |
Anita Dushyanth | Berenberg Capital |
Good morning, ladies and gentlemen and welcome to the Q4 2020 Ascendis Pharma Earnings Conference Call. [Operator Instructions] This call is being recorded. I would now like to turn the conference over to your host, Mr. Scott Smith, Senior Vice President and Chief Financial Officer of Ascendis Pharma. Please go ahead, sir.